PNV 1.24% $2.38 polynovo limited

I believe that Dr. Greenwood is continuing to use the CCS...

  1. 5,260 Posts.
    lightbulb Created with Sketch. 242
    I believe that Dr. Greenwood is continuing to use the CCS terminology, and I can’t see any substantial difference between the NovoSkin CCS and the CCS mentioned within Dr. Greenwood’s Skin Tissue Engineering venture. (See Dr. Greenwood’s linkdin profile)

    I am certain that what has happened is that PolyNovo is concentrating on its core business and is leaving bioreactors etc. to Dr. Greenwood. I expect that there will be a significant level of coordination and cooperation between PolyNovo and Skin T.E. as I believe that Dr. Greenwood will continue to use a NovoSorb scaffold.

    In short, while there may have been a rejiggering of the relationship between Dr. Greenwood and PolyNovo with respect to the CCS, I don’t think the CCS itself has changed much, although it could be subject to continuous improvement.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.38
Change
-0.030(1.24%)
Mkt cap ! $1.642B
Open High Low Value Volume
$2.42 $2.44 $2.36 $4.288M 1.798M

Buyers (Bids)

No. Vol. Price($)
4 28177 $2.37
 

Sellers (Offers)

Price($) Vol. No.
$2.38 26895 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.